Published in Fertil Steril on March 29, 2013
Fertility preservation in women. Nat Rev Endocrinol (2013) 1.50
Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet (2015) 1.25
Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. J Gynecol Oncol (2016) 1.04
Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res (2014) 0.87
Genetics of primary ovarian insufficiency: a review. J Assist Reprod Genet (2014) 0.85
Optimal timing for elective egg freezing. Fertil Steril (2015) 0.84
Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol (2015) 0.83
Live birth after 6 years of oocyte vitrification in a survivor with breast cancer. J Assist Reprod Genet (2014) 0.81
Autologous oocyte cryopreservation in women aged 40 and older using minimal stimulation IVF. Reprod Biol Endocrinol (2015) 0.81
Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet (2015) 0.80
IVF for fertility preservation in breast cancer patients--efficacy and safety issues. J Assist Reprod Genet (2015) 0.78
Ovarian tissue cryopreservation and transplantation: scientific implications. J Assist Reprod Genet (2016) 0.78
ART results with frozen oocytes: data from the Italian ART registry (2005-2013). J Assist Reprod Genet (2015) 0.76
New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators. Cell Cycle (2015) 0.76
Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model? J Assist Reprod Genet (2015) 0.76
Who benefits from putting family life into ice? Ups J Med Sci (2016) 0.75
Helping Woman with their Fertility should be part of the Agenda for Gender Equality. Facts Views Vis Obgyn (2014) 0.75
Ethical, moral and other aspects related to fertility preservation in cancer patients. JBRA Assist Reprod (2017) 0.75
Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients. Clin Med Insights Oncol (2016) 0.75
First French live-birth after oocyte vitrification performed before chemotherapy for fertility preservation. J Assist Reprod Genet (2016) 0.75
Fertility-preservation in endometrial cancer: is it safe? Review of the literature. JBRA Assist Reprod (2016) 0.75
The Human Oocyte Preservation Experience (HOPE) Registry: evaluation of cryopreservation techniques and oocyte source on outcomes. Reprod Biol Endocrinol (2017) 0.75
Current state and controversies in fertility preservation in women with breast cancer. World J Clin Oncol (2017) 0.75
Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril (2004) 4.14
Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril (2007) 3.18
Differential transcriptomic profile in spermatozoa achieving pregnancy or not via ICSI. Reprod Biomed Online (2010) 2.92
Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients. Fertil Steril (2002) 2.64
Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod (2010) 2.12
Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril (2013) 2.12
Poor responders and androgen adjuvant treatment: "Still haven't found what I'm looking for...". Reprod Biomed Online (2014) 2.01
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab (2007) 1.99
Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening. Fertil Steril (2013) 1.99
Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril (2007) 1.98
Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med (2011) 1.83
Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril (2012) 1.76
The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod (2007) 1.74
Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online (2012) 1.62
Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod (2003) 1.62
Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod (2012) 1.57
The implantation of every embryo facilitates the chances of the remaining embryos to implant in an IVF programme: a mathematical model to predict pregnancy and multiple pregnancy rates. Hum Reprod (2005) 1.51
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod (2009) 1.50
Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial. Fertil Steril (2012) 1.49
Role of cholesterol, calcium, and mitochondrial activity in the susceptibility for cryodamage after a cycle of freezing and thawing. Fertil Steril (2004) 1.48
Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod (2005) 1.46
Comparison of Cryotip vs. Cryotop for mouse and human blastomere vitrification. Fertil Steril (2011) 1.42
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril (2003) 1.41
The effectiveness of modified sperm washes in severely oligoasthenozoospermic men infected with human immunodeficiency and hepatitis C viruses. Fertil Steril (2006) 1.40
Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril (2009) 1.40
Estrogen levels and thrombophilia--an intervening variable or a confounder? Fertil Steril (2002) 1.39
Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology (2006) 1.33
Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril (2003) 1.30
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update (2008) 1.29
Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet (2012) 1.28
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril (2005) 1.27
Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology (2002) 1.21
Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril (2009) 1.19
Ontological evaluation of transcriptional differences between sperm of infertile males and fertile donors using microarray analysis. J Assist Reprod Genet (2010) 1.18
Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One (2010) 1.17
Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril (2013) 1.14
Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab (2008) 1.13
Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil Steril (2010) 1.13
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod (2007) 1.13
Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. Fertil Steril (2012) 1.12
A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril (2010) 1.10
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril (2010) 1.09
Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med (2010) 1.09
Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril (2006) 1.07
New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online (2008) 1.06
Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil Steril (2007) 1.06
Pro-oxidative and anti-oxidative imbalance in human semen and its relation with male fertility. Asian J Androl (2004) 1.05
An experimental bagatelle or a wrong mistake? Fertil Steril (2002) 1.05
Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. Mol Hum Reprod (2003) 1.03
Pregnancy outcome in women with endometriomas achieving pregnancy through IVF. Hum Reprod (2012) 1.03
Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos. Fertil Steril (2006) 1.02
Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod (2002) 1.02
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF success. Fertil Steril (2011) 1.01
Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod (2009) 1.01
Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil Steril (2008) 1.01
Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril (2012) 1.01
Impact of chromosomal abnormalities on preimplantation embryo development. Prenat Diagn (2007) 1.00
Value of the sperm deoxyribonucleic acid fragmentation level, as measured by the sperm chromatin dispersion test, in the outcome of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril (2006) 1.00
Oocyte cryopreservation for donor egg banking. Reprod Biomed Online (2011) 1.00
Storage of human oocytes in the vapor phase of nitrogen. Fertil Steril (2010) 0.99
Influence of paternal age on assisted reproduction outcome. Reprod Biomed Online (2008) 0.99
Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod (2008) 0.98
The impact of next-generation sequencing technology on preimplantation genetic diagnosis and screening. Fertil Steril (2013) 0.98
Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells. Fertil Steril (2012) 0.98
Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod (2003) 0.98
Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial. Fertil Steril (2011) 0.97
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril (2012) 0.97
Fertility preservation: moving ahead faster than expected! J Assist Reprod Genet (2014) 0.97
Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril (2012) 0.96
Efficiency and purity provided by the existing methods for the isolation of luteinized granulosa cells: a comparative study. Hum Reprod (2012) 0.96